The presentation is a succinct outline of who they are, what they've been up to, what's happening next and a few 'what might be possible' style quotes that are covered by the disclaimer at the start. As you and kates pointed out, a hefty collection of cancer specialists all well regarded. If you can construct your SAB with marketing in mind, then why not?
It's worth remembering that medical research is often worthy and well constructed without being successful. I don't think reputations suffer with failed research unless it's a real snake oil outfit. Kaumaya(especially) and Galigiuri are obvious sign-ups due to the OSU connection.
Cheers
Ann: Investor Presentation, page-21
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
